Cargando…
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
OBJECTIVE: Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is suggested that omega-3 fatty acids (FA) lower hepatic DNL. We investigated the effects of omega-3 FA supplementation o...
Autores principales: | Green, Charlotte J, Pramfalk, Camilla, Charlton, Catriona A, Gunn, Pippa J, Cornfield, Thomas, Pavlides, Michael, Karpe, Fredrik, Hodson, Leanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078804/ https://www.ncbi.nlm.nih.gov/pubmed/32188593 http://dx.doi.org/10.1136/bmjdrc-2019-000871 |
Ejemplares similares
-
Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019) -
Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020) -
Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018) -
In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum
por: Gunn, Pippa J., et al.
Publicado: (2017) -
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)